1. Home
  2. HLX vs HROW Comparison

HLX vs HROW Comparison

Compare HLX & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.64

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$42.17

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
HROW
Founded
1979
1998
Country
United States
United States
Employees
N/A
373
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HLX
HROW
Price
$8.64
$42.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$11.50
$69.86
AVG Volume (30 Days)
1.3M
774.3K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$876,561,000.00
N/A
Revenue This Year
$2.05
$31.62
Revenue Next Year
$5.46
$50.77
P/E Ratio
N/A
N/A
Revenue Growth
3.60
N/A
52 Week Low
$5.52
$28.54
52 Week High
$10.75
$54.98

Technical Indicators

Market Signals
Indicator
HLX
HROW
Relative Strength Index (RSI) 34.57 71.69
Support Level $8.58 $40.61
Resistance Level $10.54 $51.01
Average True Range (ATR) 0.34 2.10
MACD -0.09 1.08
Stochastic Oscillator 14.08 98.96

Price Performance

Historical Comparison
HLX
HROW

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: